ARCHIVES

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

FDA News: Consolidation Plan Designed For Savings

June 5, 1998

On Biomedical Malthusianism; Varmus, et al. Propose a Strategy For Saving Biomedical Research

May 2, 2014

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

December 13, 2002

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

Study Suggests Surveillance Colonoscopies Overperformed

August 27, 2004

Nursing Center Moves Onto Campus

May 9, 1986